Back to Search

JOACHIM WERNICKE, MD

MD

Specialist

NPI: 1023494994Individual

Specialties, Licenses & Credentials

SpecialistPrimary

Specialist

Code: 174400000X

01050824A(IN)

Research & Publications (20)

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
PMID 18690991·Curr Drug Saf·2008
6-review
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
PMID 18690992·Curr Drug Saf·2008
6-review
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
PMID 17716324·Pain Med·2007
4-observational
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine.
PMID 17593120·Dev Med Child Neurol·2007
8-other
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
PMID 17472422·Drug Saf·2007
1-meta
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
PMID 17060567·Neurology·2006
2-rct
Safety and adverse event profile of duloxetine.
PMID 16255658·Expert Opin Drug Saf·2005
6-review
Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methods.
PMID 16231957·Drug Saf·2005
4-observational
QT correction methods in children and adolescents.
PMID 15673393·J Cardiovasc Electrophysiol·2005
4-observational
Safety and side effect profile of fluoxetine.
PMID 15335304·Expert Opin Drug Saf·2004
6-review
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.
PMID 14709944·J Clin Psychopharmacol·2004
3-trial
Cardiovascular effects of atomoxetine in children, adolescents, and adults.
PMID 12862507·Drug Saf·2003
6-review
Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.
PMID 12562062·J Clin Psychiatry·2002
4-observational
Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
PMID 19149522·Curr Drug Saf·2009
8-other
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
PMID 18690993·Curr Drug Saf·2008
8-other
The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.
PMID 18828958·Curr Med Res Opin·2008
1-meta
Answers to the most common questions about the hepatic safety profile of duloxetine.
PMID 18654076·Postgrad Med·2008
6-review
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
PMID 18366245·Drug Saf·2008
5-case
A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
PMID 17257478·Curr Med Res Opin·2007
8-other
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
PMID 17937567·J Womens Health (Larchmt)·2007
1-meta

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
447 W 91ST ST
INDIANAPOLIS, IN 46260

Quick Facts

NPI
1023494994
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile